Patents by Inventor Daniel J. Finnemore

Daniel J. Finnemore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
    Patent number: 10442815
    Abstract: The invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof and/or stereoisomers thereof. The compounds of the invention are useful in therapy.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: October 15, 2019
    Assignee: Karus Therapeutics Limited
    Inventors: Stephen J. Shuttleworth, Franck A. Silva, Alexander R. L. Cecil, Rikki P. Alexander, Alice E. Gatland, Daniel J. Finnemore
  • TRICYCLIC HETEROCYCLIC COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE INHIBITORS
    Publication number: 20180244685
    Abstract: The invention relates to a compound of formula I: or a pharmaceutically acceptable salt thereof and/or stereoisomers thereof. The compounds of the invention are useful in therapy.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 30, 2018
    Inventors: Stephen J. Shuttleworth, Franck A. Silva, Alexander R.L. Cecil, Rikki P. Alexander, Alice E. Gatland, Daniel J. Finnemore